PubMed

Peripheral blood T4 cell surface CCR5 density as a marker of activity in rheumatoid arthritis treated with anti-CD20 monoclonal antibody.

Portalès P, Fabre S, Vincent T, Desmetz C, Réant B, Noël D, Clot J, Jorgensen C, Corbeau P.

Immunology. 2009 Sep;128(1 Suppl):e738-45. Epub 2009 Mar 26.PMID: 19740335 [PubMed - in process]Related articles

CXCR3 expression on peripheral CD4+ T cells as a predictive marker of response to treatment in chronic hepatitis C.

Perney P, Turriere C, Portalès P, Rigole H, Psomas C, Blanc F, Clot J, Corbeau P.

Clin Immunol. 2009 Jul;132(1):55-62. Epub 2009 May 6.PMID: 19423402 [PubMed - indexed for MEDLINE]Related articles

Inhibition of active nuclear transport is an intrinsic trigger of programmed cell death in trypanosomatids.

Casanova M, Portalès P, Blaineau C, Crobu L, Bastien P, Pagès M.

Cell Death Differ. 2008 Dec;15(12):1910-20. Epub 2008 Sep 12.PMID: 19011643 [PubMed - indexed for MEDLINE]Related articlesFree article

The chemokine CCL5 regulates the in vivo cell surface expression of its receptor, CCR5.

Lin YL, Mettling C, Portalès P, Rouzier R, Clot J, Reynes J, Corbeau P.

AIDS. 2008 Jan 30;22(3):430-2.PMID: 18195571 [PubMed - indexed for MEDLINE]Related articles

Small-molecule inhibition of HIV pre-mRNA splicing as a novel antiretroviral therapy to overcome drug resistance.

Bakkour N, Lin YL, Maire S, Ayadi L, Mahuteau-Betzer F, Nguyen CH, Mettling C, Portales P, Grierson D, Chabot B, Jeanteur P, Branlant C, Corbeau P, Tazi J.

PLoS Pathog. 2007 Oct 26;3(10):1530-9.PMID: 17967062 [PubMed - indexed for MEDLINE]Related articlesFree article

Cell surface CCR5 density determines the intensity of T cell migration towards rheumatoid arthritis synoviocytes.

Desmetz C, Lin YL, Mettling C, Portalès P, Noël D, Clot J, Jorgensen C, Corbeau P.

Clin Immunol. 2007 May;123(2):148-54. Epub 2007 Mar 23.PMID: 17363330 [PubMed - indexed for MEDLINE]Related articles

The strength of the chemotactic response to a CCR5 binding chemokine is determined by the level of cell surface CCR5 density.

Desmetz C, Lin YL, Mettling C, Portalès P, Rabesandratana H, Clot J, Corbeau P.

Immunology. 2006 Dec;119(4):551-61.PMID: 17177831 [PubMed - indexed for MEDLINE]Related articlesFree article

The immunological response to highly active antiretroviral therapy is linked to CD4+ T-cell surface CCR5 density.

Vincent T, Portalès P, Baillat V, Eden A, Clot J, Reynes J, Corbeau P.

J Acquir Immune Defic Syndr. 2006 Nov 1;43(3):377-8. No abstract available. PMID: 17079996 [PubMed - indexed for MEDLINE]Related articles

The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling.

Lin YL, Mettling C, Portalès P, Réant B, Robert-Hebmann V, Reynes J, Clot J, Corbeau P.

AIDS. 2006 Jun 26;20(10):1369-77.PMID: 16791011 [PubMed - indexed for MEDLINE]Related articles

Immunostimulants revisited: focus on the pharmacology of Ribomunyl.

Portalès P, Clot J.

BioDrugs. 2006;20(2):81-4.PMID: 16626165 [PubMed - indexed for MEDLINE]Related articles

CXCR4 overexpression during the course of HIV-1 infection correlates with the emergence of X4 strains.

Lin YL, Portales P, Segondy M, Baillat V, de Boever CM, Le Moing V, Réant B, Montes B, Clot J, Reynes J, Corbeau P.

J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):530-6.PMID: 16044003 [PubMed - indexed for MEDLINE]Related articles

G-protein signaling triggered by R5 human immunodeficiency virus type 1 increases virus replication efficiency in primary T lymphocytes.

Lin YL, Mettling C, Portalès P, Réant B, Clot J, Corbeau P.

J Virol. 2005 Jun;79(12):7938-41.PMID: 15919952 [PubMed - indexed for MEDLINE]Related articlesFree article

The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment.

Guillot B, Portalès P, Thanh AD, Merlet S, Dereure O, Clot J, Corbeau P.

Br J Dermatol. 2005 Apr;152(4):690-6.PMID: 15840100 [PubMed - indexed for MEDLINE]Related articles

T-Cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus/HIV-coinfected individuals: implications for the therapeutic use of CCR5 antagonists.

Vincent T, Portales P, Baillat V, de Boever CM, Le Moing V, Vidal M, Ducos J, Clot J, Reynes J, Corbeau P.

J Acquir Immune Defic Syndr. 2005 Mar 1;38(3):305-9.PMID: 15735449 [PubMed - indexed for MEDLINE]Related articles

Diminished CD4+ T cell surface CCR5 expression in alcoholic patients.

Perney P, Portalès P, Clot J, Blanc F, Corbeau P.

Alcohol Alcohol. 2004 Nov-Dec;39(6):484-5. Epub 2004 Oct 21.PMID: 15498817 [PubMed - indexed for MEDLINE]Related articlesFree article

Vitamin E supplementation increases the expression of the CCR5 coreceptor in HIV-1 infected subjects.

Portales P, Guerrier T, Clot J, Corbeau P, Mettling C, Lin YL, Baillat V, de Boever CM, Le Moing V, Tramoni C, Reynes J, Segondy M.

Clin Nutr. 2004 Oct;23(5):1244-5. No abstract available. PMID: 15380918 [PubMed - indexed for MEDLINE]Related articles

Relationship between CCR5 density and viral load after discontinuation of antiretroviral therapy.

Reynes J, Baillat V, Portales P, Clot J, Corbeau P.

JAMA. 2004 Jan 7;291(1):46. No abstract available. PMID: 14709574 [PubMed - indexed for MEDLINE]Related articlesFree article

Specific alteration of peripheral cytotoxic cell perforin expression in alcoholic patients: a possible role in alcohol-related diseases.

Perney P, Portalès P, Corbeau P, Roques V, Blanc F, Clot J.

Alcohol Clin Exp Res. 2003 Nov;27(11):1825-30.PMID: 14634500 [PubMed - indexed for MEDLINE]Related articles

Low CD4+ T-cell surface CCR5 density as a cause of resistance to in vivo HIV-1 infection.

Reynes J, Baillat V, Portales P, Clot J, Corbeau P.

J Acquir Immune Defic Syndr. 2003 Sep 1;34(1):114-6. No abstract available. PMID: 14501804 [PubMed - indexed for MEDLINE]Related articles

Perforin expression in T cells and virological response to PEG-interferon alpha2b in HIV-1 infection.

Portales P, Reynes J, Rouzier-Panis R, Baillat V, Clot J, Corbeau P.

AIDS. 2003 Mar 7;17(4):505-11.PMID: 12598770 [PubMed - indexed for MEDLINE]Related articles

Interferon-alpha restores HIV-induced alteration of natural killer cell perforin expression in vivo.

Portales P, Reynes J, Pinet V, Rouzier-Panis R, Baillat V, Clot J, Corbeau P.

AIDS. 2003 Mar 7;17(4):495-504.PMID: 12598769 [PubMed - indexed for MEDLINE]Related articles

Rare occurrence of CD30+ circulating cells in patients with cutaneous CD30+ anaplastic large cell lymphoma: a study of nine patients.

Dereure O, Portales P, Balavoine M, Corbeau P, Guillot B, Clot J, Guilhou JJ.

Br J Dermatol. 2003 Feb;148(2):246-51.PMID: 12588375 [PubMed - indexed for MEDLINE]Related articles

Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection.

Lin YL, Mettling C, Portales P, Reynes J, Clot J, Corbeau P.

Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15590-5. Epub 2002 Nov 14.PMID: 12434015 [PubMed - indexed for MEDLINE]Related articlesFree article

Continuous veno-venous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNFalpha and IL6 plasma concentrations.

Klouche K, Cavadore P, Portales P, Clot J, Canaud B, Béraud JJ.

J Nephrol. 2002 Mar-Apr;15(2):150-7.PMID: 12018631 [PubMed - indexed for MEDLINE]Related articles

Similar serum levels of soluble forms of fas and fas ligand in cutaneous T cell lymphoma and benign lymphocyte-mediated dermatoses: relevancy for defective apoptosis hypothesis.

Dereure O, Llanos F, Portales P, Clot J, Guilhou JJ.

J Invest Dermatol. 2002 May;118(5):895-6. No abstract available. PMID: 11982773 [PubMed - indexed for MEDLINE]Related articlesFree article

Response to treatment and disease progression linked to CD4+ T cell surface CC chemokine receptor 5 density in human immunodeficiency virus type 1 vertical infection.

Gervaix A, Nicolas J, Portales P, Posfay-Barbe K, Wyler CA, Segondy M, Avinens O, Siegrist CA, Clot J, Eliaou JF, Astruc J, Corbeau P.

J Infect Dis. 2002 Apr 15;185(8):1055-61. Epub 2002 Apr 1.PMID: 11930315 [PubMed - indexed for MEDLINE]Related articles

Decreased expression of fas (APO-1/CD95) on lesional CD4+ T lymphocytes in cutaneous T cell lymphomas: correlations with blood data.

Dereure O, Portales P, Clot J, Guilhou JJ.

Br J Dermatol. 2001 Dec;145(6):1031-2. No abstract available. PMID: 11899134 [PubMed - indexed for MEDLINE]Related articles

CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression.

Reynes J, Portales P, Segondy M, Baillat V, André P, Avinens O, Picot MC, Clot J, Eliaou JF, Corbeau P.

AIDS. 2001 Sep 7;15(13):1627-34.PMID: 11546936 [PubMed - indexed for MEDLINE]Related articles

Immunomodulation induced by Avène spring water on Th1- and Th2-dependent cytokine production in healthy subjects and atopic dermatitis patients.

Portalès P, Ariès MF, Licu D, Pinton J, Hernandez-Pion C, Gall Y, Dupuy P, Charveron M, Clot J.

Skin Pharmacol Appl Skin Physiol. 2001 Jul-Aug;14(4):234-42.PMID: 11464106 [PubMed - indexed for MEDLINE]Related articles

Sex differences in HIV-1 viral load due to sex difference in CCR5 expression.

Portales P, Clot J, Corbeau P.

Ann Intern Med. 2001 Jan 2;134(1):81-2. No abstract available. PMID: 11187428 [PubMed - indexed for MEDLINE]Related articlesFree article

Low dose antithymocyte globulins in renal transplantation: daily versus intermittent administration based on T-cell monitoring.

Djamali A, Turc-Baron C, Portales P, Leverson G, Chong G, Clot J, Mourad G.

Transplantation. 2000 Mar 15;69(5):799-805.PMID: 10755529 [PubMed - indexed for MEDLINE]Related articles

Decreased expression of Fas (APO-1/CD95) on peripheral blood CD4+ T lymphocytes in cutaneous T-cell lymphomas.

Dereure O, Portales P, Clot J, Guilhou JJ.

Br J Dermatol. 2000 Dec;143(6):1205-10.PMID: 11122022 [PubMed - indexed for MEDLINE]Related articles

[Low-dose antithymocyte globulins in kidney transplantation: results of a protocol of intermittent administration]

Mourad G, Portales P, Garrigue V, Djamali A, Bouloux C, Chong G, Clot J.

Nephrologie. 2000;21(5):253-8. French. PMID: 11068775 [PubMed - indexed for MEDLINE]Related articles

Reply

Reynes J, Portales P, Clot J, Corbeau P.

J Infect Dis. 2000 Oct;182(4):1285-6. No abstract available. PMID: 10979937 [PubMed - as supplied by publisher]Related articles

CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1.

Reynes J, Portales P, Segondy M, Baillat V, André P, Réant B, Avinens O, Couderc G, Benkirane M, Clot J, Eliaou JF, Corbeau P.

J Infect Dis. 2000 Mar;181(3):927-32.PMID: 10720514 [PubMed - indexed for MEDLINE]Related articles

Natural killer cell and alphabeta and gammadelta lymphocyte traffic into the liver graft immediately after liver transplantation.

Navarro F, Portalès P, Candon S, Pruvot FR, Pageaux G, Fabre JM, Domergue J, Clot J.

Transplantation. 2000 Feb 27;69(4):633-9.PMID: 10708122 [PubMed - indexed for MEDLINE]Related articles

Intracytoplasmic Th1 and Th2 cytokines in rheumatoid arthritis blood and synovial tissue.

Bourg V, Portalès P, Fiorito S, Combe B, Jorgensen C, Sany J, Clot J.

J Autoimmun. 1999 Dec;13(4):415-22.PMID: 10585757 [PubMed - indexed for MEDLINE]Related articles

Activated sub-populations of lymphocytes and natural killer cells in normal liver and liver grafts before transplantation.

Navarro F, Portalès P, Pageaux JP, Perrigault PF, Fabre JM, Domergue J, Clot J.

Liver. 1998 Aug;18(4):259-63.PMID: 9766822 [PubMed - indexed for MEDLINE]Related articles

Lymphocyte sub-population content of the liver graft before liver transplantation.

Navarro F, Portales P, Pageaux JP, Perrigaul PF, Fabre JM, Domergue J, Clot J.

Transplant Proc. 1997 Dec;29(8):3611-3. No abstract available. PMID: 9414859 [PubMed - indexed for MEDLINE]Related articles

Perforin intracytoplasmic expression by peripheral blood lymphocytes in renal transplantation.

Portalès P, Djamali A, Tinland O, Clot J, Mourad G.

Transplant Proc. 1997 Aug;29(5):2315-7. No abstract available. PMID: 9270742 [PubMed - indexed for MEDLINE]Related articles

Comparison of the pharmacodynamics of two antilymphocyte preparations in renal allograft recipients.

Turc-Baron C, Portalès P, Mourad G, Clot J.

Transplant Proc. 1995 Aug;27(4):2476. No abstract available. PMID: 7652892 [PubMed - indexed for MEDLINE]Related articles

Lethal acute graft-versus-host disease in a liver transplant recipient: relations with cell migration and chimerism.

Pageaux GP, Perrigault PF, Fabre JM, Portales P, Souche B, Dereure O, Eliaou JF, Larrey D, Domergue J, Michel H.

Clin Transplant. 1995 Feb;9(1):65-9.PMID: 7742585 [PubMed - indexed for MEDLINE]Related articles

Biclonal Sézary syndrome with capillary leak syndrome.

Dereure O, Portales P, Clot J, Guilhou JJ.

Dermatology. 1994;188(2):152-6.PMID: 8136545 [PubMed - indexed for MEDLINE]Related articles

[Antigenic specificity of antiplasmodium antibodies in an endemic area: an attempt at correlation with the induction of protective immunity]

Roffi J, Portales P, Delgado G, Parent G, Chevassus-Agnès S.

Ann Inst Pasteur Immunol. 1985 May-Jun;136C(3):323-41. French. PMID: 2412483 [PubMed - indexed for MEDLINE]Related articles

Long-term follow-up of children breast-fed by mothers receiving depot-medroxyprogesterone acetate.

Jimenez J, Ochoa M, Soler MP, Portales P.

Contraception. 1984 Dec;30(6):523-33.PMID: 6241560 [PubMed - indexed for MEDLINE]Related articles